Submit your abstract

ABSTRACT SUBMISSION IS CLOSED

Abstract review process

An international panel of scientific experts has reviewed the abstracts which are selected for an oral or poster presentation. The first (presenting) author has received a confirmation of acceptance for either an oral or poster presentation, or a notice of rejection, by email on May 31, 2016.

Harold Gunson Fellowship - renewed

All Young Investigators who are 40 years or younger could apply for the Harold Gunson Fellowship when submitting an abstract. Starting from this year it does not matter in which country you are working in. 

All successful applicants will receive complementary registration to the congress. Flight and accommodation costs are covered by ISBT.

Before you send your application please make sure that you have read the Harold Gunson Fellowship Procedure carefully and that you:

  • Are 40 years or younger at the date of the first day of the congress
  • You are the first, submitting and presenting author of an abstract which has been accepted for the scientific programme

Closing date for applications was April 28, 2016.

Please note that successful applicants from very high and high HDI countries may only receive the award once and from medium and low HDI countries twice. To find out in which category your country is in, click here.

Wacht the tutorial on 'How to get your abstract accepted and how to present' it by Geoff Daniels

ABSTRACT TOPICS

1.1 Organisational issues
1.2 Information technology
1.3 Cost/effectiveness
1.4 Training and education
1.5 Risk models, standards and regulation
1.6 Blood supply management and utilization
1.7 Quality management

2.1 Blood donor recruitment
2.2 Blood collection including apheresis
2.3 Donor adverse events

3.1 Blood processing, storage and release
3.2 Blood components
3.3 Plasma products
3.4 Pathogen inactivation
3.5 Novel blood products

4.1 Screening strategies for TTI
4.2 Hepatitis B (HBV)
4.3 Hepatitis C (HCV)
4.4 HIV
4.5 Bacteria
4.6 Parasites
4.7 Newly emerging pathogens and other transfusion related pathogens

5.1 Red cell immunology: Serology
5.2 Red cell immunology: Molecular
5.3 Platelet immunology
5.4 Granulocyte immunology
5.5 Fetal-maternal immunology

6.1 Neonatal and pediatric transfusion
6.2 Therapeutic apheresis
6.3 Evidence based transfusion medicine practice
6.4 Haemorrhage and massive transfusion
6.5 Adverse events, including TRALI
6.6 Haemovigilance and transfusion safety
6.7 Alternatives to blood transfusion

7.1 Stem cell and tissue banking, including cord blood
7.2 Collection, processing, storage and release
7.3 Clinical applications

8.1 HLA in transfusion medicine
8.2 Histocompatibility in stem cell transplantation
8.3 Histocompatibility in organ transplantation

JOIN ISBT TOGETHER WE INCREASE OUR IMPACT ON TRANSFUSION MEDICINE

Quote
Quote

“Together we improve quality in transfusion medicine: Recipients need best treatment. Donors deserve best care. Professionals need best education."

Peter van den Burg, the Netherlands
Become a member from 55,- euro p/y Join us now